There are 2789 resources available
LBA13 - Predictive impact of biomarkers on pCR and survival after de-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs. trastuzumab+ET in HER2+/HR+ early breast cancer: WSG ADAPT TP trial
Presenter: Nadia Harbeck
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
1100MO - Molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
Presenter: Halfdan Sorbye
Session: Mini oral session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1101MO - Development of CAR T-cells for future treatment of NETs
Presenter: Barbara Mandriani
Session: Mini oral session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
515MO - A phase I trial of durvalumab (Durv) in combination with olaparib (Ola) and capivasertib (Cap) in patients (pts) with advanced or metastatic cancers (Ca) (MEDIPAC)
Presenter: Joline Lim
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
516MO - Phase I/II study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with solid tumor malignancies
Presenter: Haeseong Park
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
517MO - Phase I study of the porcupine (PORCN) inhibitor RXC004 in patients with advanced solid tumours
Presenter: Natalie Cook
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
518MO - Tolerability and preliminary clinical activity of SY-5609, a highly potent and selective oral CDK7 inhibitor, in patients with advanced solid tumors
Presenter: Manish Sharma
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
121MO - Acute toxicity associated with a 3-week versus a standard 5-week regimen for locoregional breast radiotherapy delivered in the UNICANCER HypoG-01 phase III trial
Presenter: Sofia Rivera
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
122MO - Quality of life from the Penelope-B study on high-risk HR+/HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib
Presenter: José García-Saenz
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
123MO - BARBICAN: A randomized, phase II study to determine the contribution of ipatasertib to neoadjuvant chemotherapy plus atezolizumab in women with triple-negative breast cancer
Presenter: Peter Schmid
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast